IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Virginia

 

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Virginia  $ 10,613,092.92
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Adaptive Methods, Inc Rapid Portable Biosensor $ 75,000.00 $ 169,479.25
Api Genesis LLC Therapeutic Flavonoid Formulations   $ 244,479.25
Axon Nutritioinals Inc Food and Therapeutic Supplement Development and Contaminant $ 7,500.00 $ 1,000.00
Bioproximity, LLC Amyloidosis Diagnostic Development via Global Proteomic Characterization $ 76,303.90 $ 64,787.94
BIOSPHEREX LLC Human Microblome Blowmarkers and Molecular Diagnostic Discovery Project $ 58,692.50 $ 185,786.75
Biovista Inc Dimebon (BVA-101) Drug Candidate for Projressive Multipie Sclerosis $ 151,577.50 $ 92,901.74
Biovista, Inc Dimebon (BVA-601) Drug Candidate for Epilepsy $ 143,491.50 $ 100,987.74
Biovista, Inc. Pirlindol Mesylate (BVA-201), Drug Candidate for Progressive Multiple Sclerosis $ 171,976.00 $ 72,503.24
Cary Pharmaceuticals Inc. Quitpak Smoking Cessation Drug $ 5,600.22 $ 238,879.02
CEL-SCI CORPORATION MULTIKINE IMMUNOTHERAPY AGENT FOR HEAD AND NECK CANCER ("Multikine") $ 244,479.25  
CEL-SCI Corporation CEL-2000 Therapeutic drug for rheumatoid arthritis (CEL-2000) $ 83,182.50 $ 161,296.75
CEL-SCI Corporation Leaps H1N1 Therapeutic Agent for H1N1 Pandemic Influenza (Leaps H1N1) $ 244,479.25  
Ceres Nanosciences Ceres Nanotrap $ 170,228.00 $ 74,251.25
Clavgen Therapeutics LLC Development of Universal Multivariate Biomarkers for Predicting Chemotherapeutic Response in Bladder and Ovarian Cancers $ 195,820.48  
Dalos BiopHARMA LLC Flavokine's effect in basal cell carcinomas   $ 24,000.00
Dalos BioPharma, LLC Flavokine's effect in Staphylococcus bacterial infections, including MRSA   $ 24,000.00
Diffusion Pharmaceuticals, LLC Trans Sodium Crocetinate (TSC) for the Treatment of Hypoxic Conditions $ 244,479.24  
Dilon Technologies, Inc BREAST SPECIFIC GAMMA IMAGING FOR EARLY DETECTION OF BREAST CANCER AND MONITORING OF TUMOR RESPONSE IN NEOADJUVANT CHEMOTHERAPY PATIENTS $ 100,361.00 $ 144,118.24
Euclid Systems Corporation Decorin Ophthalmic Solution $ 244,479.24  
EYERX Research, Inc. Lacritin, a novel therapeutic for dry eye   $ 13,819.50
Gencia Corp Pre-Clinical Development for the treatment of Alzheimer's and Sarcopenia $ 224,164.00 $ 20,315.25
Gene Solutions, LLC Parkinson's Disease Diagnostic Development $ 17,147.50 $ 5,352.50
GPB Scientific, LLC Therapeutic Stem Cells from Umbilcal Cord Blood $ 244,479.25  
Health Diagnostic Laboratory Inc High Density Lipoprotein Associated Apolipoprotein E Quantitation $ 244,479.25  
Health Diagnostic Laboratory, Inc. Vitamin and Mineral Testing for Nutritional Status $ 244,479.25  
HemoShear LLC Human Surrogate Model of the Liver $ 79,221.00 $ 165,258.24
HemoShear, LLC Human Surrogate Diabetes Vascular Model   $ 244,479.24
Hypogen Inc Targeted Therapeutics for Hypertension and/or Salt Sensitivity   $ 5,000.00
Hypogen Inc Salt Sensitivity Urine Test   $ 5,000.00
Innovative Technologies, LLC Breast Cancer Diagnostic Drug(ITL-1636) $ 244,479.25  
Instantlabs Medical Diagnostic Corporation Enabling Accel. Real-Time Polymerase Chain Reaction (ART-PCR) at point -of-need $ 244,479.25  
Jericho Sciences, LLC Novel Long-term Antiviral Therapeutic $ 2,365.00 $ 242,114.24
John F. Hunt Alkalinization of Inhaled Therapeutics. $ 5,760.00 $ 3,667.00
Lestoni Corp Targeting Tumor Hypoxia as New Cancer Therapy $ 99,303.00 $ 145,176.24
Medgenics, Inc. The Biopump Protein Factory $ 244,479.25  
Medical Predictive Science Corporation Impact of HeRO Monitoring in Neonates $ 244,479.24  
Molecules for Health, Inc Accelerating Development of Didox, a Unique Multifaceted Drug, Towards Clinical Usage $ 32,518.00 $ 119,588.50
OCUCURE THERAPEUTICS, INC. OC-10X: Topical treatment of Macular Degeneration and Diabetic Retinopathy $ 244,479.24  
OCULAR OPTICS, INC. Sapphire TM Auto Focal IOL $ 244,479.25  
Osteologix Inc NB S101 $ 244,479.24  
Parabon NanoLabs Inc A novel Nano-Pharmaceutical for the treatment of Glioblastoma Multiforme $ 38,352.47 $ 92,028.90
Phthisis Diagnostics, LLC R-Sphere Cypto-Giardia Detect $ 173,299.50 $ 71,179.74
Phtsisis Diagnostics, LLC R-Sphere Microsporidia Detect   $ 35,916.50
PluroGen Therapeutics, Inc. New Topical Antibiotic with Unique Antimicrobial, Physical, Bio-impace and Multi-function $ 160,570.31 $ 83,908.94
Pocketsonics Inc Pocket-Sized, Low-Cost, Ultrasound Imaging Device $ 143,783.00 $ 100,696.25
Revivicor Inc New therapies using human compatible cells and organs from genetically engineered pigs $ 244,479.25  
Skyentia Technologies LLC Novel Therapeutic for Neuroprotection in Stroke and Traumatic Brain injury $ 1,592.48 $ 1,790.41
SYNTHONICS INC METALLO-ZANAMIVIR $ 62,737.00 $ 86,333.50
Synthonics Inc Metallo-SAHA $ 64,834.50 $ 76,873.00
Synthonics Inc Metallo - Topiramate $ 61,746.50 $ 66,791.50
Synthonics, Inc Metallo-Levodopa $ 118,318.00 $ 126,161.25
Tau Therapeutics LLC Interlaced Therapy with Mibefradil for the Treatment of Glioblastoma Multiforme $ 169,518.52 $ 74,960.73
Techulon, Inc. Glycofect Biodegradable Transfection Reagent $ 48,619.50 $ 84,000.00
Toxem LLC Botanical Drug for DIC in snakebite, sepsis and traumatic brain injury $ 51,360.92 $ 193,118.33
WellAWARE Systems, Inc WellAWARE $ 244,479.25  
Zansors LLC Commercializing Micro/Nana sensors for obesity detection using bio-sensor technologies   $ 244,479.24

 

Page Last Reviewed or Updated: 25-Mar-2014